pfizervaccine

Pfizer claims COVID-19 vaccine more than 90% effective in children aged 5 to 11

Pfizer's Covid-19 vaccine is more than 90% effective in preventing symptomatic illness in children aged 5 to 11, according to…

3 years ago

The Pfizer booster shot was 95.6 percent effective against Covid-19

BioNTech stated in a tweet, "During a time when Delta was the most common strain, our #mRNA vaccine provided 95.6…

3 years ago

Novartis extends contract to manufacture Pfizer/BioNTech vaccines

Novartis intends to purchase bulk mRNA active ingredient from BioNTech and fill it into sterile vials for shipment back to…

3 years ago

The state Won’t Buy Pfizer, MS As Local Outputs Jumps: Report

New Delhi: India will not buy Pfizing/BioNTech and Moderna shots from COVID-19, according to three government sources, mainly as domestic…

3 years ago

Healthy boys with a Pfizer side-effect are more likely to get hospitalised than Covid-19

The second dose of Pfizer-BioNTech Covid-19 vaccine will more likely result in the hospitalisation of healthy young people with a…

3 years ago

In October, US Decision Pfizer COVID-19 shot at children aged 5-11, sources say

The two sources familiar with the situation said Friday that top U.S. health workers believe Pfizer Inc.'s COVID-19 vaccine could…

3 years ago

Australia announces that Pfizer is dealing with the UK coronavirus switch

Prime Minister Scott Morrison said on Friday, days after the notice of a lesser swap arrangement with Singapore, Australia is…

3 years ago

Covid-19, a vaccine developed by Pfizer and BioNTech, may receive final approval in the United States next week

The United States Food and Drug Administration (FDA) is expected to provide complete approval to Pfizer-two-dose BioNTech's coronavirus vaccine (Covid-19)…

3 years ago

According to a study, Pfizer’s COVID-19 vaccine is losing effectiveness faster than AstraZeneca’s

According to a new study released on August 19, the effectiveness of the Pfizer-BioNTech vaccine against COVID-19 falls faster than…

3 years ago

Pfizer plans to begin testing of an upgraded version of the Covid vaccine soon

Pfizer Inc announced on Wednesday that an immunogenicity and safety study to examine an upgraded version of the Covid-19 vaccine…

3 years ago